Bespoke Extracts (BSPK) Net Cash Flow Growth (5y) (2016 - 2021)
Bespoke Extracts (BSPK) Net Cash Flow Growth (5y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | -18.61% |
| Aug 31, 2021 | -53.92% |
| May 31, 2021 | -58.21% |
| Feb 28, 2021 | 36.17% |
| Nov 30, 2020 | 32.95% |
| May 31, 2020 | 3.63% |
| Feb 29, 2020 | 17.42% |
| Nov 30, 2019 | 27.60% |
| Aug 31, 2019 | -6.87% |
| May 31, 2019 | 16.01% |
| Feb 28, 2019 | 53.17% |
| Nov 30, 2018 | -35.19% |
| Aug 31, 2018 | -19.42% |
| May 31, 2018 | 73.10% |
| Feb 28, 2018 | 15.15% |
| Nov 30, 2017 | 18.06% |
| May 31, 2017 | -27.74% |
| Feb 28, 2017 | -57.49% |
| Nov 30, 2016 | -44.33% |